Aug 4, 2026 10:05AM
Aug 4, 2026 09:16AM
Aug 4, 2026 06:55AM
Aug 3, 2026 04:01PM
Jul 13, 2026 07:42AM
Jun 1, 2026 08:01AM
Jun 1, 2026 08:00AM Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
Mar 9, 2026 05:35PM
Jan 23, 2026 12:56PM
Nov 10, 2025 10:01AM
Oct 1, 2025 01:20PM
Jul 20, 2025 08:00PM
Jan 27, 2025 07:50AM
Jan 24, 2025 07:33AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
Jan 13, 2025 12:50PM
Jan 12, 2025 05:01PM
Dec 19, 2024 01:40PM
Dec 19, 2024 06:00AM
Dec 19, 2024 06:00AM
Nov 13, 2024 04:08PM
Nov 5, 2024 01:11PM Oppenheimer Reiterates Outperform Rating on Vertex (VRTX)
Nov 4, 2024 04:01PM
Oct 21, 2024 06:05AM
Oct 18, 2024 08:00AM
Oct 18, 2024 08:00AM
Sep 26, 2024 07:08AM
Sep 26, 2024 07:07AM
Aug 5, 2024 07:46AM Vertex (VRTX) PT Raised to $550 at Oppenheimer
Aug 2, 2024 07:45AM
Aug 1, 2024 04:01PM
Jul 30, 2024 01:10PM
Jul 30, 2024 01:10PM
Jul 2, 2024 08:33AM
Jul 2, 2024 08:33AM
Jan 16, 2024 02:24PM Vertex Pharma (VRTX) Announces US FDA Approval of CASGEVY for Treatment of Transfusion-Dependent Beta Thalassemia
Jan 16, 2024 02:24PM
Jan 8, 2024 05:26AM
Jan 7, 2024 03:00PM
Dec 12, 2023 03:21AM
Dec 11, 2023 07:30PM
Dec 8, 2023 12:55PM
Dec 8, 2023 12:52PM Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease
Nov 16, 2023 04:53AM
Nov 16, 2023 01:45AM
Nov 6, 2023 04:01PM
Aug 1, 2023 04:01PM
Jun 9, 2023 05:35AM
Jun 9, 2023 05:29AM
Jun 9, 2023 03:01AM Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress
Jun 8, 2023 07:23PM

15,649 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All